Pharmaceutical Procurement

Pharmaceutical procurement is the systematic, competitive purchasing of finished medicines, active pharmaceutical ingredients (APIs), and biologicals by public institutions at national and international levels. In the international development context, it is dominated by UN agencies and the Global Fund, which together supply essential medicines to dozens of low- and middle-income countries.

What is Pharmaceutical Procurement?

International pharmaceutical procurement is distinct from commercial drug purchasing in that it applies quality gatekeeping before price competition. Suppliers must hold WHO prequalification for the specific medicine being tendered, or authorisation from a stringent regulatory authority (SRA) such as the US FDA, EMA, or equivalent. Only prequalified products from prequalified manufacturers are eligible; price competition happens within that approved pool. The World Bank's $5.3 billion annual health portfolio includes substantial medicine supply, typically procured by government health ministries as MDB borrowers using icb or ncb procedures.

UNICEF Supply Division is the world's largest buyer of essential medicines for children and of HIV, tuberculosis, and malaria treatments acting through pooled procurement on behalf of multiple countries. The lta is the dominant contract vehicle: UNICEF establishes multi-year supply agreements at negotiated prices, then places call-off orders as country programmes require. WHO's Access to Medicines list and the Global Fund's Pooled Procurement Mechanism follow similar architectures.

Why Pharmaceutical Procurement matters for bidders

Pharmaceutical manufacturers that achieve WHO prequalification open access to a market worth billions of dollars annually in development institution purchasing alone. The investment in prequalification - dossier preparation, factory audits, and ongoing compliance - is significant but creates a durable competitive advantage because the pool of eligible suppliers for any given product is relatively small. Firms should monitor WHO prequalification lists to identify products where they could qualify and where the competitive field is thin. Once qualified, maintaining registration on ungm with accurate product codes and pursuing LTA placement with UNICEF and the Global Fund are the highest-value commercial activities.

FAQ

What is WHO prequalification for pharmaceuticals?

WHO prequalification is a quality assessment process that certifies a medicine's formulation, manufacturing site, and quality control meet international standards, making it eligible for procurement by UN agencies and GAVI-funded programmes.

Which organisations run the largest pooled pharmaceutical procurement programmes?

UNICEF Supply Division, the Global Fund, PAHO PRASS (Pan American revolving fund), and the African Union's African Medicines Agency are among the largest pooled medicine buyers at international level.

Can generic manufacturers compete in international pharmaceutical tenders?

Yes. WHO prequalified generic manufacturers are fully eligible and often dominate international tenders on price, particularly for HIV antiretrovirals and antimalarials where the generic market is well developed.